Journal list menu
Export Citations
Download PDFs
Head and Neck Cancer
PLEK2 promotes cancer stemness and tumorigenesis of head and neck squamous cell carcinoma via the c-Myc-mediated positive feedback loop
- First Published: 24 August 2022
Low-dose metronomic chemotherapy improves tumor control in nasopharyngeal carcinoma
- First Published: 04 August 2022
Nasopharyngeal carcinoma treatment paradigm after HK0501 – a potential way forward
- First Published: 01 August 2022
Transcriptome-wide association analysis identified candidate susceptibility genes for nasopharyngeal carcinoma
- First Published: 01 June 2022
A multimodal integrative approach to model transcriptional addiction of thyroid cancer on RUNX2
- First Published: 22 April 2022
Matrisomal genes in squamous cell carcinoma of head and neck influence tumor cell motility and response to cetuximab treatment
- First Published: 02 March 2022
Aberrant translation regulated by METTL1/WDR4-mediated tRNA N7-methylguanosine modification drives head and neck squamous cell carcinoma progression
- First Published: 18 February 2022
JUPITER-02 trial: advancing survival for recurrent metastatic nasopharyngeal carcinoma and next steps
- First Published: 16 December 2021
The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma
- First Published: 26 October 2021
A novel intronic circular RNA, circGNG7, inhibits head and neck squamous cell carcinoma progression by blocking the phosphorylation of heat shock protein 27 at Ser78 and Ser82
- First Published: 09 September 2021
The role of non-coding RNAs in drug resistance of oral squamous cell carcinoma and therapeutic potential
- First Published: 20 July 2021

The mechanisms of drug resistance are intricate and involve drug efflux, epithelial mesenchymal transition, DNA damage repair, and autophagy. Nano-delivery and self-cellular drug delivery platforms have a broad prospective for alleviating OSCC drug resistance. In particular, the combined application of new technologies (including CRISPR systems) opens up new horizons for treatment of OSCC drug resistance.
Retreatment in locally recurrent nasopharyngeal carcinoma: Current status and perspectives
- First Published: 06 May 2021
Individualized elective irradiation of the clinically node-negative neck in definitive radiotherapy for head and neck squamous cell carcinoma
- First Published: 26 February 2021

Framework of individualized and computer-aided elective neck irradiation. Firstly, we proposed individual elective neck irradiation schemes for head and neck squamous cell carcinoma. based on the actual incidence of lymph nodes metastasis and the tumor characteristics. Secondly, we developed a publicly available online tool to facilitate the widespread clinical use of these schemes. By inputting the characteristics of the primary tumor and metastatic LNs on this online tool, elective irradiation schemes for the right and left sides of the neck were recommended and delineated based on a set of CT scans.
Phase III trial of docetaxel cisplatin 5-fluorouracil induction chemotherapy for resectable oral cancer suggests favorable pathological response as a surrogate endpoint for good therapeutic outcome
- First Published: 20 January 2021
Development and validation of a web-based calculator to predict individualized conditional risk of site-specific recurrence in nasopharyngeal carcinoma: Analysis of 10,058 endemic cases
- First Published: 03 December 2020
ZNF582 hypermethylation promotes metastasis of nasopharyngeal carcinoma by regulating the transcription of adhesion molecules Nectin-3 and NRXN3
- First Published: 10 October 2020
Clinical utility of Epstein-Barr virus DNA and other liquid biopsy markers in nasopharyngeal carcinoma
- First Published: 28 September 2020
Emerging radiotherapy technologies and trends in nasopharyngeal cancer
- First Published: 03 August 2020
Surgery as an alternative to radiotherapy in early-stage nasopharyngeal carcinoma: innovation at the expense of uncertainty
- First Published: 18 March 2020
Other Head and Neck Cancer articles
Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma
You-Ping Liu, Xing Lv, Xiong Zou, Yi-Jun Hua, Rui You, Qi Yang, Le Xia, Shao-Yan Guo, Wen Hu, Meng-Xia Zhang, Si-Yuan Chen, Mei Lin, Yu-Long Xie, Li-Zhi Liu, Rui Sun, Pei-Yu Huang, Wei Fan, Xiang Guo, Ming-Huang Hong, Ming-Yuan Chen
Published: 15 November 2019